Q1 2026 Earnings Call April 29, 2026 4:25 PM EDTCompany ParticipantsStan Finkelstein - Head of Investor RelationsMike Slessor - ...
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...
The next evolution of the finance function isn’t about controlling cybersecurity spend; it’s about controlling cyber exposure ...
Consolidated Revenue -- $136.8 million, up 14.3% driven by growth in Genie Retail Energy (GRE). GRE Revenue -- $132.5 million ...
In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a ...
YouTube on MSNOpinion
The 12-year-old, the statin, and the story we tell ourselves
A 12-year-old athlete prescribed a statin sparked a deeper question: are we treating numbers or people? This letter unpacks ...
Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...
Greetings, and welcome to the Microsoft Fiscal Year 2026 Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to ...
Parents who gain access to usage logs can see just how much time their children spend inside YouTube's recommendation engine ...
NR3C1 encodes the glucocorticoid receptor (GR) and regulates stress responses, metabolism, immune function, and inflammation, ...
There’s a general consensus that too much screen time is bad for kids. But what happens when everything in modern society is ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient popu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results